ANALYZE PATHOLOGY INC. NPI 1396384251

NPI Details

ANALYZE PATHOLOGY INC. is an anatomic pathology and clinical pathology pathology in Deerfield Beach, FL. The provider is a pathologist deals with the causes and nature of disease and contributes to diagnosis, prognosis and treatment through knowledge gained by the laboratory application of the biologic, chemical and physical sciences. A pathologist uses information gathered from the microscopic examination of tissue specimens, cells and body fluids, and from clinical laboratory tests on body fluids and secretions for the diagnosis, exclusion and monitoring of disease. ANALYZE PATHOLOGY INC. NPI is 1396384251. The provider is registered as an organization entity type and is a multi-specialty group.

The provider's business location address is:

160 SW 12TH AVE UNIT 103
DEERFIELD BEACH, FL
ZIP 33442-119
Phone: (561) 507-0522
Fax: (561) 431-2922

The provider's authorized official is Anna Dzeva .
The authorized official title is Ceo and has the following contact phone number (561) 507-0522.

The CLIA number assigned to this NPI record is 10D2303094 - industrial with a certificate type of Certificate of Accreditation.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Testing for presence of drug, by chemistry analyzers (HCPCS:80307)
• Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source (HCPCS:G2023)
• Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (HCPCS:G0483)
• Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (HCPCS:G0481)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
• Pathology examination of tissue using a microscope, intermediate complexity (HCPCS:88305)

The enumeration date for this NPI number is 12/24/2019 and was last updated on 4/24/2025.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.